ABI-2280 Vaginal Insert
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABI-2280 Vaginal Insert, covering 2026-02-19 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ABI-2280 Vaginal Insert (Previously Referred to as ABI-2280 Vaginal Tablet) in Participants With Cervical Intraepithelial Neoplasia [Phase 1, Phase 2]